Literature DB >> 11325764

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

E J Sijbrands1, R G Westendorp, J C Defesche, P H de Meier, A H Smelt, J J Kastelein.   

Abstract

OBJECTIVE: To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease.
DESIGN: Family tree mortality study.
SETTING: Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century.
SUBJECTS: All members of pedigree aged over 20 years with 0.5 probability of carrying a mutation for familial hypercholesterolaemia. MAIN OUTCOME MEASURE: All cause mortality.
RESULTS: A total of 70 deaths took place among 250 people analysed for 6950 person years. Mortality was not increased in carriers of the mutation during the 19th and early 20th century; it rose after 1915, reached its maximum between 1935 and 1964 (standardised mortality ratio 1.78, 95% confidence interval 1.13 to 2.76; P=0.003), and fell thereafter. Mortality differed significantly between two branches of the pedigree (relative risk 3.26, 95% confidence interval 1.74 to 6.11; P=0.001).
CONCLUSIONS: Risk of death varies significantly among patients with familial hypercholesterolaemia. This large variability over time and between branches of the pedigree points to a strong interaction with environmental factors. Future research is required to identify patients with familial hypercholesterolaemia who are at extreme risk and need early and vigorous preventive measures.

Entities:  

Mesh:

Year:  2001        PMID: 11325764      PMCID: PMC31037          DOI: 10.1136/bmj.322.7293.1019

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

1.  Mortality in hereditary antithrombin-III deficiency--1830 to 1989.

Authors:  F R Rosendaal; H Heijboer; E Briët; H R Büller; D P Brandjes; K de Bruin; D W Hommes; J P Vandenbroucke
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

2.  Competing mortality and progress against cancer.

Authors:  R B Rothenberg
Journal:  Epidemiology       Date:  1994-03       Impact factor: 4.822

3.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

Authors:  M Seed; F Hoppichler; D Reaveley; S McCarthy; G R Thompson; E Boerwinkle; G Utermann
Journal:  N Engl J Med       Date:  1990-05-24       Impact factor: 91.245

4.  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  BMJ       Date:  1991-10-12

5.  Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing.

Authors:  P Lombardi; E J Sijbrands; K van de Giessen; A H Smelt; J J Kastelein; R R Frants; L M Havekes
Journal:  J Lipid Res       Date:  1995-04       Impact factor: 5.922

6.  Serum cholesterol and acute myocardial infarction: a case-control study from the GISSI-2 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico Investigators.

Authors:  A Nobili; B D'Avanzo; L Santoro; G Ventura; P Todesco; C La Vecchia
Journal:  Br Heart J       Date:  1994-05

7.  Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling.

Authors:  M J Kotze; H J Davis; S Bissbort; E Langenhoven; J Brusnicky; C J Oosthuizen
Journal:  Clin Genet       Date:  1993-06       Impact factor: 4.438

8.  Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease.

Authors:  R R Williams; S C Hunt; P N Hopkins; L L Wu; M C Schumacher; B M Stults; L Ball; J Ware; S J Hasstedt; J M Lalouel
Journal:  Clin Exp Pharmacol Physiol Suppl       Date:  1992

9.  South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.

Authors:  J C Defesche; D E van Diermen; P J Lansberg; R J Lamping; P W Reymer; M R Hayden; J J Kastelein
Journal:  Hum Genet       Date:  1993-12       Impact factor: 4.132

10.  Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.

Authors:  J S Hill; M R Hayden; J Frohlich; P H Pritchard
Journal:  Arterioscler Thromb       Date:  1991 Mar-Apr
View more
  27 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 2.  Genetic variation and lipid metabolism: modulation by dietary factors.

Authors:  Jose M Ordovas; Dolores Corella
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

3.  The origins of human disease: a short story on "where diseases come from".

Authors:  Johan P Mackenbach
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

4.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Authors:  Amanda M Perak; Hongyan Ning; Sarah D de Ferranti; Holly C Gooding; John T Wilkins; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

5.  PCSK9 inhibition and the global diabetes epidemic.

Authors:  Luca Mascitelli; Mark R Goldstein
Journal:  Diabetologia       Date:  2017-01-29       Impact factor: 10.122

Review 6.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

7.  Low-density lipoprotein apheresis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

8.  Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis.

Authors:  S Matthijs Boekholdt; Ron J G Peters; Katerina Fountoulaki; John J P Kastelein; Eric J G Sijbrands
Journal:  Hum Genet       Date:  2003-08-26       Impact factor: 4.132

9.  Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia.

Authors:  Jeroen B van der Net; Daniëlla M Oosterveer; Jorie Versmissen; Joep C Defesche; Mojgan Yazdanpanah; Bradley E Aouizerat; Ewout W Steyerberg; Mary J Malloy; Clive R Pullinger; John J P Kastelein; John P Kane; Eric J G Sijbrands
Journal:  Eur Heart J       Date:  2008-07-03       Impact factor: 29.983

10.  Mortality risk prediction by an insurance company and long-term follow-up of 62,000 men.

Authors:  Eric J G Sijbrands; Erik Tornij; Sietske J Homsma
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.